In-Licensing & Out-Licensing
In-Licensing & Out-Licensing
Strategic licensing partnerships that connect innovation with opportunity — accelerating the delivery of breakthrough therapies to global markets.
At ARYVAX, we support strategic In-Licensing and Out-Licensing partnerships that enable healthcare and biopharmaceutical companies to maximize asset value and accelerate growth across global markets. Our licensing services are designed to create mutually beneficial collaborations by aligning scientific innovation with commercial opportunity.
We assist partners throughout the entire licensing lifecycle — from opportunity identification, market assessment, and due diligence to deal structuring, negotiation support, and post-agreement execution. By combining therapeutic expertise, market intelligence, and regulatory insight, ARYVAX helps identify high-potential assets and optimal partners that align with long-term strategic objectives.
We enable companies to strengthen and diversify their portfolios by accessing innovative products, technologies, and platforms with strong market potential. Our evaluation process focuses on clinical value, regulatory feasibility, market demand, and commercialization readiness to support informed decision-making.
- Portfolio diversification through innovative product access
- Clinical value and regulatory feasibility assessment
- Market demand analysis and commercialization readiness
- Due diligence and opportunity identification
- Deal structuring and negotiation support
ARYVAX helps innovators unlock the full value of their assets by identifying suitable regional or global partners and designing licensing strategies that expand reach while maintaining strategic control. We support positioning, partner engagement, and negotiation processes to ensure sustainable value creation and long-term success.
- Identifying suitable regional and global partners
- Licensing strategies that expand market reach
- Asset positioning and partner engagement
- Negotiation process management
- Sustainable value creation and long-term success
Our Approach
Our approach emphasizes transparency, risk mitigation, and alignment across regulatory, commercial, and operational considerations — delivering efficient deal execution and successful post-licensing collaboration.
Opportunity Identification
We scan global markets to identify high-potential assets and partners that align with your therapeutic focus and long-term strategic objectives.
Market Assessment & Due Diligence
In-depth analysis of clinical data, regulatory pathways, market demand, pricing landscapes, and competitive positioning to support sound decision-making.
Deal Structuring & Negotiation
Expert guidance through term sheet development, contract negotiations, milestone structuring, and royalty frameworks to achieve mutually beneficial agreements.
Risk Mitigation
Proactive identification and management of regulatory, commercial, and operational risks to protect your interests throughout the licensing lifecycle.
Global Partner Network
Leveraging our extensive network of global healthcare partners, distributors, and innovators to connect the right parties for maximum strategic impact.
Post-Agreement Execution
Ongoing support after deal closure — ensuring seamless integration, compliance monitoring, and sustained collaboration for long-term value creation.